Evidence map›Paper›PMID 32948195›Full record

ArticleBMC medical genomics2020

Mutation profiling in eight cases of vagal paragangliomas.

Anna V Kudryavtseva, Dmitry V Kalinin, Vladislav S Pavlov, Maria V Savvateeva, Maria S Fedorova, Elena A Pudova, Anastasiya A Kobelyatskaya, Alexander L Golovyuk, Zulfiya G Guvatova, George S Razmakhaev and 9 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Recent Trends in Cancer Genomics and Bioinformatics Tools Development.International journal of molecular sciences · 2021
    Article
  4. Article
  5. Tackling Dysfunction of Mitochondrial Bioenergetics in the Brain.International journal of molecular sciences · 2021
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Anna V KudryavtsevaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. rhizamoeba@mail.ru.
Dmitry V KalininVishnevsky Institute of Surgery, Ministry of Health of the Russian Federation, Moscow, Russia.
Vladislav S PavlovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Maria V SavvateevaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Maria S FedorovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Elena A PudovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Anastasiya A KobelyatskayaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Alexander L GolovyukVishnevsky Institute of Surgery, Ministry of Health of the Russian Federation, Moscow, Russia.
Zulfiya G GuvatovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
George S RazmakhaevNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Tatiana B DemidovaA. N. Severtsov Institute of Ecology and Evolution, Russian Academy of Sciences, Moscow, Russia.
Sergey A SimanovskyA. N. Severtsov Institute of Ecology and Evolution, Russian Academy of Sciences, Moscow, Russia.
Elena N SlavnovaNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Andrey А PoloznikovNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Andrey P PolyakovNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Nataliya V MelnikovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Alexey A DmitrievEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
George S KrasnovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Anastasiya V SnezhkinaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.ORCID 0000-0002-4421-4364
Engelhardt Institute of Molecular Biology · RUMinistry of Health of the Russian Federation · RUSevertsov Institute of Ecology and Evolution · RU

Funding

Russian Science Foundation 19-15-00419
6 · The paper itself

Abstract

backgroundVagal paragangliomas (VPGLs) belong to a group of rare head and neck neuroendocrine tumors. VPGLs arise from the vagus nerve and are less common than carotid paragangliomas. Both diagnostics and therapy of the tumors raise significant challenges. Besides, the genetic and molecular mechanisms behind VPGL pathogenesis are poorly understood.

methodsThe collection of VPGLs obtained from 8 patients of Russian population was used in the study. Exome library preparation and high-throughput sequencing of VPGLs were performed using an Illumina technology.

resultsBased on exome analysis, we identified pathogenic/likely pathogenic variants of the SDHx genes, frequently mutated in paragangliomas/pheochromocytomas. SDHB variants were found in three patients, whereas SDHD was mutated in two cases. Moreover, likely pathogenic missense variants were also detected in SDHAF3 and SDHAF4 genes encoding for assembly factors for the succinate dehydrogenase (SDH) complex. In a patient, we found a novel variant of the IDH2 gene that was predicted as pathogenic by a series of algorithms used (such as SIFT, PolyPhen2, FATHMM, MutationTaster, and LRT). Additionally, pathogenic/likely pathogenic variants were determined for several genes, including novel genes and some genes previously reported as associated with different types of tumors.

conclusionsResults indicate a high heterogeneity among VPGLs, however, it seems that driver events in most cases are associated with mutations in the SDHx genes and SDH assembly factor-coding genes that lead to disruptions in the SDH complex.

Indexed as

MutationAdultAgedCranial Nerve NeoplasmsDNA Mutational AnalysisFemaleHigh-Throughput Nucleotide SequencingHumansMiddle AgedParagangliomaSuccinate DehydrogenaseVagus Nerve DiseasesSuccinate DehydrogenaseExomeHigh-throughput sequencingPathogenic/likely pathogenic mutationsSDHx genesSHD assembly factor-coding genesVagal paraganglioma

Identifiers

PMID32948195
PMCPMC7500026
OpenAlexW3087188432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.